Tripletail Wealth Management’s Pfizer PFE Stock Holding History

Tripletail Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-292	Closed	-$7.68K	–	326
2025 Q3	$7.68K	Buy	+292	New	+$7.21K	0.01%	266

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tripletail Wealth Management's PFE Position: Q4 2025 in Review

Tripletail Wealth Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 292 shares — an estimated $7.68K sold.

Tripletail Wealth Management first reported a position in PFE in Q3 2025 and held it in 1 quarter. The position peaked at $7.68K in Q3 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Tripletail Wealth Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Tripletail Wealth Management sold 292 Pfizer shares in Q4 2025, an estimated $7.68K.
Tripletail Wealth Management first reported a position in Pfizer in Q3 2025 and held it in 1 quarter.
Tripletail Wealth Management's Pfizer position peaked at $7.68K in Q3 2025.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Tripletail Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.